Cadila Healthcare Limited's wholly owned subsidiary Liva Pharmaceuticals Ltd. has received USFDA approval for Haloperidol Decanoate Injection.

The following stocks would be in focus during Friday’s trading session in light of their results announcement: Jubilant Life Sciences , State Bank of India, Tata Motors, V2 Retail and HeidelbergCement India.

Key indices made optimistic start, as investors took some encouragement after India jumped 14 places to the 63rd position on the World Bank's ease of doing business ranking, riding high on the government's flagship Make in India scheme and other reforms attracting foreign investment.

Alembic Pharmaceuticals announced that its joint venture named Aleor Dermaceuticals received approval for Desonide Ointment, 0.05 per cent from USFDA.

Bharat Sanchar Nigam Limited (BSNL) sees this as a very important step from the government. According to the latest published financial numbers by the company, its net loss stood Rs. 8000 crore in fiscal 2018 while MTNL, for FY19, reported net loss of Rs. 3390 crore.

Aurobindo Pharma has informed the exchanges on receiving final approval from the US Food & Drug Administration (USFDA) for Guaifenesin tablets.

Most of the people depend on EPF balances, NPS balances, annuities, etc. to ride through retirement. However, ignoring the risks that are involved in retirement can create a problem. So, what are those risks? Let’s find out.

Profit after tax in Q2FY20 more than doubled to Rs. 193.8 crore from Rs. 89.5 crore in Q2FY19. Further, the company recorded 222 bps and 778 bps improvement in ROCE and ROE to 26.3 per cent and 22 per cent for Q2FY20 respectively.

Dr Reddy's Laboratories on Wednesday said that it has voluntarily recalled all its Ranitidine medicines from US market due to contamination with probable cancer causing N-Nitrosodimethylamine (NDMA).